 |
 |
 |
   |
 |
|
Spasticity
Spasticity Bibliography Part 1 Treatment Overviews Brin MF, ed. Spasticity: Etiology, Evaluation, Management, and the Role of Botulinum Toxin Type A. New York: Wiley, 1997 Glenn MB, Whyte J (editors). The Practical Management of Spasticity in Children and Adults. Philadelphia: Lea & Febiger, 1990 Gormley ME, O'Brien CF, Yablon SA. A Clinical Overview of Treatment Decisions in the Management of Spasticity. In: Brin MF, ed. Spasticity: Etiology and Assessment. New York: Wiley, 1999 Lazar RB (editor). Principles of Neurological Rehabilitation. New York: McGraw-Hill, 1998 Overview Ashby P & McCrea DA. Neurophysiology of spinal spasticity. In: Handbook of the spinal cord. Volume 4/5. Ed by RA Davidoff. New York (1987): Marcel Dekker, pp 119-143 Denny-Brown D. The cerebral control of movement. Liverpool(1966): Liverpool University Press Lance JW. Symposium synopsis. In: Spasticity: disordered motor control. pp 485-494 Feldman RG, Young RR, Koella WP, eds. Chicago (1980): Yearbook Medical Other References - click here Overview Pierson, SH. Outcome Measures in Spasticity Management. In: Brin MF, ed. Spasticity: Etiology and Assessment. New York: Wiley, 1999: Other References Carr JH, Shepherd RB, Nordholm L & Lynne D (1985). A motor assessment scale for stroke. Phys Ther 65: 175-180 Goff B (1976). Grading of spasticity and its effect on voluntary movement. Physiotherapy 62: 358-361 Grangers CV, Dewis LS, Peters NC et al. (1979). Stroke rehabilitation: analysis of repeated Barthel index measures. Arch. Phys. Med. Rehab. 60: 14-17 Lincoln N & Leadbitter D (1979). Assessment of motor function in stroke patients. Physiotherapy 65: 48-51 Physical and Occupational Therapy; Contracture Treatment References Ada L & Canning C (1990). Anticipating and avoiding muscle shortening. In : Ada L & Canning C (Eds), Key issues in Neurological Physiotherapy. Series: Physiotherapy: Foundations for Practice, Series Editors: Janet H Carr & Roberta B Shepherd. Oxford, Butterworth-Heinemann Ltd Bernard P, et al. Reduction of hypertonicity by early casting in a comatose head-injured individual: A case report. Phys Ther 1984;64:1540-1542. Blair E, Ballantyne J, Horsman S & Chauvel P (1995). A study of a dynamic proximal stability splint in the management of children with cerebral palsy. Dev Med Child Neurol 37: 544-554 Booth BJ, Doyle M & Montgomery J (1983). Serial casting for the management of spasticity in the head-injured adult. Phys Ther 63, 12, 1960. Brunnstrom S (1970). Movement therapy in hemiplegia. New York: Harper & Row Carr JH & Shepherd RB (1987). A motor relearning program for stroke. 2nd edition. Oxford: Heinemann Medical Feldman P. Upper Extremity Casting and Splinting. In: Glenn M, Whyte J, eds. The Practical Management of Spasticity in Children and Adults. Philadelphia: Lea & Febiger, 1990: Geibler K. Physical Modalities. In: Glenn M, Whyte J, eds. The Practical Management of Spasticity in Children and Adults. Philadelphia: Lea & Febiger, 1990: Gracies JM, Fitzpatrick R, Wilson L, Burke D, Gandevia SC (1997). Lycra garments designed for patients with upper limb spasticity: mechanical effects in normal subjects. Arch Phys Med & Rehab, 78: 1066-1071 Hallenborg SC. Positioning. In: Glenn M, Whyte J, eds. The Practical Management of Spasticity in Children and Adults. Philadelphia: Lea & Febiger, 1990: Hayes NK, Burns YR (1970). Discussion on the use of weight-bearing plasters in the reduction of hypertonicity. Aust. J. Physiother., 16, 3, 108 King TI. Plaster splinting as a means of reducing elbow flexor spasticity: a case study. Am.J.Occup.Ther. 1982;36:671-673. Nash J, Neilson PD & O'Dwyer NJ (1989). Reducing spasticity to control muscle contracture of children with cerebral palsy. Dev Med Child Neurol 31: 471-480 O'Dwyer NJ, Neilson PD & Nash J (1994). Reduction of spasticity in cerebral palsy using feedback of the tonic stretch reflex: a controlled study. Dev Med Child Neurol 36: 770-786 O'Dwyer NJ, Ada L & Neilson PD (1996). Spasticity and muscle contracture following stroke. Submitted to Brain. Perry J (1980). Rehabilitation of Spasticity. In : Spasticity: Disordered Motor Control. Feldman RG, Young RR, Werner KP, Eds. Chicago: Year Book, pp 87-99. Tardieu C, Lespargot A, Tabary C & Bret MD (1988). For how long must the soleus muscle be stretched each day to prevent contracture? Dev Med Child Neurol 30: 3-10 Williams PE (1990). Use of intermittent stretch in the prevention of serial sarcomere loss in immobilised muscle. Ann Rheum Dis, 49, 316 Overview Other references Ashworth B (1964). Preliminary trial of carisoprodol in multiple sclerosis. Practitioner 192: 540-542 Basmajian JV, Yucel V. Effects of a GABA--derivative (BA-34647) on spasticity. Preliminary report of a double-blind cross-over study. Am.J Phys Med. 1974;53:223-228. Bass B, Weinshenker B, Rice GP, et al. Tizanidine versus baclofen in the treatment of spasticity in patients with multiple sclerosis. Can.J.Neurol.Sci. 1988;15:15-19. Duncan GW, Shahani BT, Young RR. An evaluation of baclofen treatment for certain symptoms in patients with spinal cord lesions. A double-blind, cross-over study. Neurology 1976;26:441-446. Cartlidge NE, Hudgson P, Weightman D. A comparison of baclofen and diazepam in the treatment of spasticity. J.Neurol.Sci. 1974;23:17-24. Corbett M, Frankel HL, Michaelis L. A double blind, cross-over trial of Valium in the treatment of spasticity. Paraplegia. 1972;10:19-22. Engle HA. The effect of diazepam (Valium) in children with cerebral palsy: a double-blind study. Dev.Med.Child Neurol. 1966;8:661-667. Feldman RG, Kelly Hayes M, Conomy JP. Baclofen for spasticity in multiple sclerosis; double blind crossover and three year study. Neurology 1978;28:1094-1094. From A, Heltberg A. A double-blind trial with baclofen (Lioresal) and diazepam in spasticity due to multiple sclerosis. Acta Neurol.Scand. 1975;51:158-166. Glass A, Hannah A. A comparison of dantrolene sodium and diazepam in the treatment of spasticity. Paraplegia. 1974;12:170-174. Haslam RH, Walcher JR, Lietman PS, Kallman CH, Mellits ED. Dantrolene sodium in children with spasticity. Arch.Phys.Med.Rehabil. 1974;55:384-388. Hoogstraten MC, van der Ploeg RJ, v, Vreeling A, van Marle S, Minderhoud JM. Tizanidine versus baclofen in the treatment of spasticity in multiple sclerosis patients. Acta Neurol.Scand. 1988;77:224-230. Katrak PH, Cole A, Poulos CJ & McCauley JCK (1992). Objective assessment of spasticity, strength, and function with early exhibition of dantrolene sodium after cerebrovascular accident: a randomized double-blind study. Arch. Phys. Med. Rehabil. 73: 4-9 Lataste X, Emre M, Davis C, Groves L. Comparative profile of tizanidine in the management of spasticity. Neurology 1994;44:53-59. Marsh HO. Diazepam in incapacitated cerebral-palsied children. JAMA. 1965;191:797-800. Nance PW, Shears AH, Nance DM (1989). Reflex changes induced by clonidine in spinal cord injured patients. Paraplegia 27: 296-301 Pinder RM, Brogden RN, Speight TM, Avery GS. Dantrolene Sdium: a review of its pharmacological properties and therapeutic efficacy in spasticity. Drugs. 1977;13:3-27. Roussan M, Terrence C, Fromm G. Baclofen versus diazepam for the treatment of spasticity and long-term follow-up of baclofen therapy. Pharmatherapeutica. 1985;4:278-284. Schmidt RT, Lee RH, Spehlemann R. Comparison of dantrolene sodium and diazepam in the treatment of spasticity. J.Neurol.Neurosurg.Psychiatry 1976;39:350-350. Stein R, Nordal HJ, Offedal SI, Slettebo M. The treatment of spasticity in multiple sclerosis; a double blind clinical trial of a new anti spastic drug tizanidine compared with baclofen. Acta Neurol.Scand. 1987;75:190-190. Wallace JD. Summary of combined clinical analysis of controlled clinical trials with tizanidine. Neurology 1994;44:S60-S69 Young RR, Delwaide PJ (1981). Drug therapy: spasticity. N Engl J Med 304: 28-33, 96-99 Overviews Brin M.F Dosing, administration, and a treatment algorithm for use of botulinum toxin A for adult-onset spasticity. Spasticity Study Group. Muscle Nerve Suppl 1997;6:S208-20 Other References Borg-Stein J, Pine ZM, Miller JR, Brin MF (1993). Botulinum toxin for the treatment of spasticity in multiple sclerosis. New observations. Am J of Phys Med & Rehab 72 (6): 364-368 Brans JW, Aramideh M, Koelman JH, Lindeboom R, Speelman JD, Ongerboer d, V. Electromyography in cervical dystonia: changes after botulinum and trihexyphenidyl. Neurology 1998;51:815-819. Brin MF, The Spasticity Study Group. Dosing, administration, and a treatment algorithm for use of botulinum toxin A for adult-onset spasticity. Muscle Nerve 1997;20:S208-S220 Burbaud P, Wiart L, Dubos JL, et al. A randomised, double blind, placebo controlled trial of botulinum toxin in the treatment of spastic foot in hemiparetic patients. J Neurol Neurosurg.Psychiatry 1996;61:265-269. Carpenter EB (1983). Role of nerve blocks in the foot and ankle in cerebral palsy: therapeutic and diagnostic. Foot Ankle 4: 164-166 Chutorian A, Root L, BTA Study Group. A multicentered, randomized, double-blind placebo-controlled trial of botulinum toxin type A in the treatment of lower limb spasticity in pediatric cerebral palsy. Mov.Disord. 1995;10:364(Abstract) Comella CL, Buchman AS, Tanner CM, Goetz CG, Brown Toms NC. Comparison of clinical versus EMG-guided botulinum toxin (Botox) injections for spasmodic torticollis. Neurology 1991;41 (Suppl 1):273-274. Corry IS, Cosgrove AP, Walsh EG, McClean D, Graham HK. Botulinum toxin A in the hemiplegic upper limb: a double-blind trial [see comments]. Dev.Med.Child Neurol. 1997;39:185-193. Das TK & Park DM (1989 a). Effect of treatment with botulinum toxin on spasticity. Postgrad Med J 65: 208-210 Das TK & Park DM (1989 b). Botulinum toxin in treating spasticity. British J of Cli. Practice 43 (11): 401-403 Dengler R, Neyer U, Wohlfahrt K, Bettig U & Janzik HH (1992). Local botulinum toxin in the treatment of spastic drop foot. J of Neurol 239: 375-378 Dunne JW, Heye N & Dunne S (1995). Treatment of chronic limb spasticity with botulinum toxin A. J Neurol Neurosurg & Psychiatry 58: 232-235 Gassel MD & Diamantopoulos E (1964). The effect of procaine nerve block on neuromuscular reflex regulation in man (an appraisal of the role of fusimotor system). Brain 87: 729-742 Glenn MB (1990). Nerve blocks. In: The practical management of spasticity in children and adults. Glenn MB & Whyte J Eds, Lea & Fibiger, Philadelphia-London, pp 227-258 Halpern D & Meelhuysen FE (1966). Phenol motor point block in the management of muscular hypertonia. Arch Phys Med Rehab 47: 659-664 Hassan SM, Jennekens FGI, Wienecke G & Veldman H (1994). Elimination of superfluous neuromuscular junctions in rat calf muscles recovering from botulinum toxin-induced paralysis. Muscle & Nerve 17: 623-631 Hesse S, Friedrich H, Domasch C & Mauritz KH (1992). Botulinum toxin therapy for upper limb flexor spasticity: preliminary results. J Rehab Sci 5: 98-101 Hesse S, Lücke D, Malezic M, Bertelt C, Friedrich H, Gregoric M & Mauritz KH (1994) Botulinum toxin treatment for lower limb extensor spasticity in chronic hemiparetic patients. J Neurol Neurosurg and Psychiatry 57: 1321-1324 Kirazli Y, On AY, Kismali B, Aksit R. Comparison of phenol block and botulinus toxin type A in the treatment of spastic foot after stroke: a randomized, double-blind trial. Am.J.Phys.Med.Rehabil. 1998;77:510-515. Koman LA, Mooney JF 3d, Smith BP, Goodman A & Mulvaney T (1993). Management of cerebral palsy with botulinum-A toxin: preliminary investigation. J. of Ped. Orthop. 13 (4): 489-495 Koman LA, Mooney JF 3d, Smith BP, Goodman A & Mulvaney T (1994). Management of spasticity in cerebral palsy wth botulinum-A toxin: report of a preliminary, randomized, double-blind trial. J. of Ped. Orthop. 14 (3): 299-303 Koman LA, Ferrarri E, Mubarak S et al (1995). Botulinum toxin type A (BTA) in the treatment of lower limb spasticity associated with cerebral palsy. Dev Med Child Neurol 37: 19-20 Konstanzer A, Ceballos-Baumann AO, Dressnandt J & Conrad B (1993). Lokale Injektionsbehandlung mit Botulinum-Toxin A bei schwerer Arm- und Beinspastik. (Local injection treatment with botulinum toxin A in severe arm and leg spasticity). Nervenarzt 64 (8): 517-523 Leach, J. Children undergoing treatment with botulinum toxin: The role of the physical therapist. Muscle and Nerve, S194-S207. 1997. Albany, K. Physical and occupational therapy considerations in adult patients receiving botulinum toxin injections for spasticity. Muscle and Nerve, S221-S231. 1997. Memin B, Pollak P, Hommel M & Perret J (1992). Traitement de la spasticity par la toxine botulique. Rev Neurol (Paris) 148 (3): 212-214 Nathan PW (1969). Treatment of spasticity with perineural injections of phenol. Dev Med Child Neurol 11: 384- O'Brien CF. Injection techniques for botulinum toxin using electromyography and electrical stimulation. Muscle Nerve Suppl. 1997;6:S176-S180 Polo KB & Jabbari B (1994). Effectiveness of botulinum toxin type A against painful limb myoclonus of spinal cord origin. Mov Dis 9(2): 233-235 Ranson SW & Dixon HH (1928). Elasticity and ductility of muscle in myostatic contracture caused by tetanus toxin. Am J Physiol 86: 312-319 Simpson DM. Clinical trials of botulinum toxin in the treatment of spasticity. Muscle Nerve 1997;20 (suppl 6):S169-S175 Simpson DM, Alexander DN, O'Brien CF, et al. Botulinum toxin type a in the treatment of upper extremity spasticity: a randomized, double-blind, placebo-controlled trial. Neurology 1996;46:1306-1310. Snow BJ, Tsui JKC, Bhatt MH, Varelas M, Hashimoto SA & Calne DB (1990). Treatment of spasticity with botulinum toxin: a double blind study. Ann. Neurol. 28: 512-515 Tardieu G, Hariga J, Tardieu C, Gagnard L & Velin J (1964). Traitement de la spasticity par infiltration d'alcool dilue au point moteur ou par injection epidurale. Rev Neurol (Paris) 110: 563-565 Tardieu G, Tardieu C, Hariga J, Gagnard L (1968 a). Treatment of spasticity by injection of dilute alcohol at the motor point or by epidural route. Clinical extension of an experiment on the decerebrate cat. Dev Med Child Neurol 10 (5): 555-568 Overview Gianino JM, York MM, Paice JA. Intrathecal Drug Therapy for Spasticity and Pain: Practical Patient Management. New York: Springer, 1996 Other References Albright AL, Barron WB, Fasick MP, Polinko P, Janosky J. Continuous intrathecal baclofen infusion for spasticity of cerebral origin. JAMA. 1993;270:2475-2477. Albright AL. Intrathecal baclofen in cerebral palsy movement disorders. J.Child Neurol. 1996;11 Suppl 1:S29-35:S29-S35 Coffey RJ, Cahill D, Steers W, et al. Intrathecal Baclofen for Intractable Spasticity of Spinal Origin - Results of a Long-Term Multicenter Study. J.Neurosurg. 1993;78:226-232. Denys P, Mane M, Azouvi P, Chartier-Kastler E, Thiebaut JB, Bussel B. Side effects of chronic intrathecal baclofen on erection and ejaculation in patients with spinal cord lesions. Arch.Phys.Med.Rehabil. 1998;79:494-496. Gianino JM, York MM, Paice JA, Shott S. Quality of life: effect of reduced spasticity from intrathecal baclofen. J.Neurosci.Nurs. 1998;30:47-54. Lazorthes Y, Sallerin-Caute B, Verdie JC, Bastide R & Carillo JP (1990). Chronic intrathecal baclofen administration for control of severe spasticity. J Neurosurg 72: 393-402 65. Middel B, Kuipers-Upmeijer H, Bouma J, et al. Effect of intrathecal baclofen delivered by an implanted programmable pump on health related quality of life in patients with severe spasticity. J.Neurol.Neurosurg.Psychiatry 1997;63:204-209. Ochs G, Struppler A, Meyerson BA, Linderoth B, Gybels J, et al. Intrathecal baclofen for long-term treatment spasticity: a multi-centre study. J.Neurol Neurosurg.Psychiatry 1989;52:933-939. Penn Rd, Savoy SM, Corcos D, Catash M, Gottlieb G, Parke B & Kroin JS (1989). Intrathecal baclofen for severe spinal spasticity. N Engl J Med 320: 1517-1521 Reeves RK, Stolp-Smith KA, Christopherson MW. Hyperthermia, rhabdomyolysis, and disseminated intravascular coagulation associated with baclofen pump catheter failure. Arch.Phys.Med.Rehabil. 1998;79:353-356. Overview Other References Chambers HG. The surgical treatment of spasticity. Muscle Nerve Suppl. 1997;6:S121-S128 Hays RM, McLaughlin JF, Bjornson KF, Stephens K, Roberts TS, Price R. Electrophysiological monitoring during selective dorsal rhizotomy, and spasticity and GMFM performance [see comments]. Dev.Med.Child Neurol. 1998;40:233-238. McLaughlin JF, Bjornson KF, Astley SJ, et al. Selective dorsal rhizotomy: efficacy and safety in an investigator- masked randomized clinical trial [see comments]. Dev.Med.Child Neurol. 1998;40:220-232. Oppenheim DL, Staudt LA. The rationale for rhizotomy. In: Sussman MD, ed. The Diplegic Child. Rosemont, IL: American Academy of Orthopedic Surgeons, 1992:271-285. Peacock WJ, Arens LJ. Selective posterior rhizotomy for the relief of spasticity in cerebral palsy. S.Afr.Med.J. 1982;62:119-124. Peacock WJ, Arens LJ, Berman B. Cerebral palsy spasticity. selective posterior rhizotomy. Pediatr Neurosci. 1987;13:61-66. Peacock WJ, Staudt LA. Functional outcomes following selective posterior rhizotomy in children with cerebral palsy. J Neurosurg. 1991;74:380-385. Sindou M. (1992). Microsurgical DREZ-tomy for the treatment of pain and spasticity. In: Principles and practice of restorative neurology pp 144-151 Young RR, Delwaide PJ, eds. Oxford, Butterworth/Heinemann Steinbok P, Reiner AM, Beauchamp R, Armstrong RW, Cochrane DD, Kestle J. A randomized clinical trial to compare selective posterior rhizotomy plus physiotherapy with physiotherapy alone in children with spastic diplegic cerebral palsy [published erratum appears in Dev Med Child Neurol 1997 Nov;39(11):inside back cover]. Dev.Med.Child Neurol. 1997;39:178-184. Steinbok P, Schrag C. Complications after selective posterior rhizotomy for spasticity in children with cerebral palsy. Pediatr.Neurosurg. 1998;28:300-313. Subramanian N, Vaughan CL, Peter JC, Arens LJ. Gait before and 10 years after rhizotomy in children with cerebral palsy spasticity. J.Neurosurg. 1998;88:1014-1019. Wright FV, Sheil EM, Drake JM, Wedge JH, Naumann S. Evaluation of selective dorsal rhizotomy for the reduction of spasticity in cerebral palsy: a randomized controlled tria [see comments]. Dev.Med.Child Neurol. 1998;40:239-247. Overview Overview Other References 
|
|
| All contents copyright © WE MOVE 2008. This page last modified 4/1/2008. | |